|
- People With Severe Diabetes Are Cured in Small Trial of New . . .
A person’s conventional supplies for treating type 1 diabetes A single infusion of a new treatment, called zimislecel, may have cured 10 out of 12 people with the most severe form of the disease
- Mount Sinai Researchers Move Closer to a Cure for Diabetes
For more than 15 years, researchers at the Icahn School of Medicine at Mount Sinai have worked tirelessly to find a solution to cure diabetes by identifying a drug that could make human beta cells regenerate
- Son’s diabetes diagnosis sent scientist on quest for cure
Over the decades, Melton and his colleagues made a series of discoveries that laid the groundwork for a new treatment to restore insulin production in patients with Type 1 diabetes Melton compares this stem cell-derived islet therapy to “educating” a stem cell and its descendants — introducing the protein signals that trigger or inhibit
- One Step Closer to a Cure: Breakthrough “Harmine Pill” Sparks . . .
Researchers at Mount Sinai have discovered how harmine-family drugs can regenerate human beta cells by converting abundant alpha cells in the pancreas, offering a scalable solution for diabetes treatment
- Islet cell transplant trial outcome ‘major milestone’ toward . . .
Amanda Smith, the first Canadian to receive an islet cell transplant to give her blood sugar control akin to a non-diabetic, says taking anti-rejection pills for life is a breeze compared with
- Scientists close to creating ‘simple pill’ that cures diabetes
Researchers at Mount Sinai have taken a significant step toward making this possibility a reality, uncovering a groundbreaking approach that could potentially help over 500 million people
- Decades in pursuit of a diabetes cure | Penn Medicine
That’s why patients may still experience severe long-term effects of diabetes even with insulin treatment: blindness, circulation problems, nerve damage, kidney failure, stroke, seizures—and, of course, hypoglycemic attacks
|
|
|